HCA HEALTHCARE, INC.

(HCA)
  Report
Real-time Estimate Cboe BZX  -  01:07 2022-07-06 pm EDT
167.73 USD   -2.81%
09:57aBMO Capital Downgrades HCA Healthcare to Underperform From Market Perform, Adjusts Price Target to $160 From $233
MT
07/01Mizuho Securities Adjusts HCA Healthcare's Price Target to $210 from $260, Keeps Buy Rating
MT
06/28UBS Adjusts HCA Healthcare Price Target to $207 From $241, Maintains Buy Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 50 13455 64979 90850 995--
Enterprise Value (EV)1 83 23584 860113 03686 09185 51684 210
P/E ratio 14,7x15,0x12,1x10,2x9,13x8,20x
Yield 1,10%0,26%0,75%1,29%1,39%1,45%
Capitalization / Revenue 0,98x1,08x1,36x0,84x0,80x0,76x
EV / Revenue 1,62x1,65x1,92x1,42x1,34x1,25x
EV / EBITDA 8,44x8,45x8,94x7,16x6,76x6,26x
Price to Book -18,3x98,8x-90,5x-20,6x-40,0x194x
Nbr of stocks (in thousands) 339 178338 375311 023295 484--
Reference price (USD) 148164257173173173
Announcement Date 01/28/202002/02/202101/27/2022---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 51 33651 53358 75260 60563 76267 475
EBITDA1 9 85710 03712 64412 02112 64313 460
Operating profit (EBIT)1 7 2617 3169 7919 0609 63910 270
Operating Margin 14,1%14,2%16,7%14,9%15,1%15,2%
Pre-Tax Profit (EBT)1 5 2445 4309 8337 4508 0208 731
Net income1 3 5053 7546 9565 1535 4645 843
Net margin 6,83%7,28%11,8%8,50%8,57%8,66%
EPS2 10,110,921,217,018,921,1
Dividend per Share2 1,630,431,922,232,392,50
Announcement Date 01/28/202002/02/202101/27/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 15 27615 06414 94514 79715 16315 746
EBITDA1 3 2243 1492 9442 8563 0053 210
Operating profit (EBIT)1 2 5082 4212 2122 1032 2652 461
Operating Margin 16,4%16,1%14,8%14,2%14,9%15,6%
Pre-Tax Profit (EBT)1 3 1572 5861 8141 6901 9202 067
Net income1 2 2691 8141 2731 1381 2811 440
Net margin 14,9%12,0%8,52%7,69%8,45%9,14%
EPS2 7,005,754,143,744,284,87
Dividend per Share ------
Announcement Date 10/22/202101/27/202204/22/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 33 10129 21133 12835 09734 52133 215
Net Cash position1 ------
Leverage (Debt / EBITDA) 3,36x2,91x2,62x2,92x2,73x2,47x
Free Cash Flow1 3 4446 3975 3824 8625 3895 913
ROE (Net Profit / Equities) ---1 568%216%228%
Shareholders' equity1 ---3292 5262 558
ROA (Net Profit / Asset) 8,32%8,11%14,2%10,1%10,6%11,0%
Assets1 42 12746 27449 11651 16551 75953 228
Book Value Per Share2 -8,061,66-2,84-8,37-4,320,89
Cash Flow per Share2 21,826,927,328,030,434,6
Capex1 4 1582 8353 5774 1174 2854 490
Capex / Sales 8,10%5,50%6,09%6,79%6,72%6,65%
Announcement Date 01/28/202002/02/202101/27/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Key data
Capitalization (USD) 50 994 697 752
Net sales (USD) 58 752 000 000
Number of employees 244 000
Sales / Employee (USD) 240 787
Free-Float 75,6%
Free-Float capitalization (USD) 38 576 043 906
Avg. Exchange 20 sessions (USD) 404 907 217
Average Daily Capital Traded 0,79%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA